Tripurrte Pharmaceuticals Private Limited
About Tripurrte Pharmaceuticals Private Limited
Data last updated:
Tripurrte Pharmaceuticals Private Limited is a private limited company based in Pha, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 07 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24110TG2018PTC126577. Its GSTIN is 36AAGCT9186M1ZG (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Thirupathi Madaka (Managing Director) and Sambireddy Madaka.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 129 Survey No.53 54 & 55 Part Rajalingam Residency Phase 1 Boduppal, Telangana, India – 500039.
As per the financials filed for FY 2024, the company reported a revenue of ₹22.16 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹2,993 (net margin 0.1%) and EBITDA of ₹4,008 (EBITDA margin 0.2%). Revenue has grown at a compounded annual rate (CAGR) of 82% over three years.
Company details
Contact details
Tripurrte Pharmaceuticals Private Limited's registered office is in Pha, Telangana.
- Registered AddressPlot No 129 Survey No.53 54 & 55 Part Rajalingam Residency Phase 1 Boduppal, Telangana, India – 500039
- IndustryChemicals, Manufacturing, Basic Chemical, Basic Chemicals Except Fertilizers And Nitrogen Compounds
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Tripurrte Pharmaceuticals is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Tripurrte Pharmaceuticals Private Limited, buy the company report.
Financials of Tripurrte Pharmaceuticals Private Limited
FY 2025 filings availableTripurrte Pharmaceuticals Private Limited reported revenue of ₹22.16 Lakh (up 257% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 82% over three years, including 257% growth in the latest year. EBITDA rose 101% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4,008 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2,993 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tripurrte Pharmaceuticals Private Limited, buy the company report.
Board of directors of Tripurrte Pharmaceuticals Private Limited
Tripurrte Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Thirupathi Madaka | Managing Director | 07 Sep 2018 | 8 Years 2 Months | Current |
| Sambireddy Madaka | Director | 07 Sep 2018 | 8 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Tripurrte Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tripurrte Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Tripurrte Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCT9186M1ZG | Telangana | Active | 11 Dec 2018 |
To see the full GST registrations and return filing status of Tripurrte Pharmaceuticals Private Limited, buy the company report.
Recent activity
Tripurrte Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Sambireddy Madaka was appointed as Director on 07 Sep 2018.
Frequently asked questions
Tripurrte Pharmaceuticals is an active private limited company based in Pha, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 07 September 2018 (8+ years old) and is registered under CIN U24110TG2018PTC126577.
Tripurrte Pharmaceuticals has 2 current directors:
- Thirupathi Madaka - Managing Director
- Sambireddy Madaka - Director
The latest financial statements of Tripurrte Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Tripurrte Pharmaceuticals is 36AAGCT9186M1ZG, registered in Telangana.
The CIN (Corporate Identification Number) of Tripurrte Pharmaceuticals is U24110TG2018PTC126577. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tripurrte Pharmaceuticals was incorporated on 07 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
Sambireddy Madaka was appointed as Director on 07 Sep 2018. Thirupathi Madaka was appointed as Managing Director on 07 Sep 2018.
The registered office of Tripurrte Pharmaceuticals is at Plot No 129 Survey No.53 54 & 55 Part Rajalingam Residency Phase 1 Boduppal, Telangana, India – 500039.
Tripurrte Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Tripurrte Pharmaceuticals can be reached at its registered office: Plot No 129 Survey No.53 54 & 55 Part Rajalingam Residency Phase 1 Boduppal, Telangana, India – 500039.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
